Page 37 | Certara

Blog

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

GSK shares real-world case studies on how Model-Based Meta-Analysis (MBMA) supports dose selection, virtual control…

CertaraJuly 31, 2025

On-Demand Webinar

Certara’s Simcyp Educational Webinar Series Part 4: Changes in Drug Absorption after Meals and the Reality of Prediction Using Modeling Approaches [in Japanese]

The Japanese educational webinar series provides essential insights into in vitro data analysis and the…

CertaraJuly 30, 2025

Blog

Recapping a record-breaking 2025 Krakow HTA Symposium

We cover the key takeaways from CERTAINTY 2025, including the power of Model-Informed Drug Development…

Simona ColucciJuly 30, 2025

Blog

Scanning research collections against generic definitions

A case study of finding substances controlled by generic definitions in a chemical library with…

CertaraJuly 30, 2025

Blog

Challenges in implementing a reliable highly-similar detection algorithm

Dive into the challenges of creating a reliable algorithm for detecting controlled substance analogues and…

CertaraJuly 30, 2025

Blog

Introduction to Controlled Substance Analogues and Generic Definitions

Learn everything there is about controlled substance analogues, generic definitions and the evolution of controlled…

CertaraJuly 30, 2025

Case Study

Optimizing Dosing and Regulatory Outcomes in Duchenne Muscular Dystrophy (DMD) Drug Development

Certara supported DMD drug development for Givinostat, helping Italfarmaco with pharmacometric and regulatory strategy.

CertaraJuly 29, 2025

On-Demand Webinar

Insights Without Animals: Leveraging Human-on-a-Chip & PBPK Modeling

CertaraJuly 29, 2025

On-Demand Webinar

MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines

Learn how clinical pharmacologists and modeling experts collaborate to improve preclinical-to-clinical translation.

CertaraJuly 29, 2025

On-Demand Webinar

Boosting Confidence in Drug Discovery with PBPK

Explore Simcyp Discovery Version 2 updates to boost early-stage drug development.

CertaraJuly 25, 2025

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

Certara’s Simcyp Educational Webinar Series Part 4: Changes in Drug Absorption after Meals and the Reality of Prediction Using Modeling Approaches [in Japanese]

Recapping a record-breaking 2025 Krakow HTA Symposium

Scanning research collections against generic definitions

Challenges in implementing a reliable highly-similar detection algorithm

Introduction to Controlled Substance Analogues and Generic Definitions

Optimizing Dosing and Regulatory Outcomes in Duchenne Muscular Dystrophy (DMD) Drug Development

Insights Without Animals: Leveraging Human-on-a-Chip & PBPK Modeling

MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines

Boosting Confidence in Drug Discovery with PBPK

Newsletter sign up

Quick links

Solutions

Contact